Epclusa — Medica
Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 3, 4, 5, or 6, decompensated cirrhosis (Child-Pugh B or C), prior null responder, prior partial responder, and prior relapser to sofosbuvir/velpatasvir or Vosevi
Initial criteria
- age ≥ 3 years
- Patient has decompensated cirrhosis (Child-Pugh B or C)
- Previously treated with sofosbuvir/velpatasvir or Vosevi
- Medication will be prescribed in combination with ribavirin
- Prescribed by or in consultation with a gastroenterologist, hepatologist, infectious diseases physician, or liver transplant physician
Approval duration
24 weeks